The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Diclofenac. The metabolism of Diclofenac can be decreased when combined with Ticlopidine. The risk or severity of adverse effects can be increased when Diclofenac is combined with Apocynin. The metabolism of Diclofenac can be decreased when combined with Clotrimazole. The risk or severity of adverse effects can be increased when Diclofenac is combined with Pregnenolone. Diclofenac may decrease the antihypertensive activities of Aliskiren. The risk or severity of bleeding can be increased when Betrixaban is combined with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Budesonide. The risk or severity of adverse effects can be increased when Diclofenac is combined with Ketorolac. The metabolism of Diclofenac can be decreased when combined with Idelalisib. The risk or severity of adverse effects can be increased when Temocapril is combined with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Atamestane. The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Diclofenac. Diclofenac may increase the neuroexcitatory activities of Enoxacin. The serum concentration of Lithium can be increased when it is combined with Diclofenac. The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Diclofenac. The serum concentration of Diclofenac can be increased when it is combined with Osimertinib. Diclofenac may increase the neuroexcitatory activities of Fleroxacin. The risk or severity of adverse effects can be increased when Diclofenac is combined with Estrone. Diclofenac may decrease the excretion rate of Streptomycin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Diclofenac is combined with Zaltoprofen. The risk or severity of adverse effects can be increased when Diclofenac is combined with Oxyphenbutazone. Diclofenac may increase the anticoagulant activities of Gabexate. The risk or severity of adverse effects can be increased when Enalapril is combined with Diclofenac. The serum concentration of Pralatrexate can be increased when it is combined with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Oleoyl-estrone. The metabolism of Diclofenac can be decreased when combined with Desipramine. The serum concentration of Diclofenac can be increased when it is combined with Sulfisoxazole. The risk or severity of adverse effects can be increased when Diclofenac is combined with Methylprednisolone. The metabolism of Diclofenac can be decreased when combined with Armodafinil. The metabolism of Diclofenac can be decreased when combined with Sulfamethoxazole. Diclofenac may increase the anticoagulant activities of Citric Acid. The risk or severity of adverse effects can be increased when Diclofenac is combined with Clocortolone. Diclofenac may decrease the excretion rate of Plazomicin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Diclofenac is combined with Rofecoxib. The metabolism of Diclofenac can be decreased when combined with Quinine. The risk or severity of adverse effects can be increased when Diclofenac is combined with Beclomethasone dipropionate. The risk or severity of adverse effects can be increased when Spirapril is combined with Diclofenac. The metabolism of Diclofenac can be decreased when combined with Thiotepa. Diclofenac may increase the neuroexcitatory activities of Gatifloxacin. Diclofenac may increase the anticoagulant activities of Dicoumarol. The risk or severity of adverse effects can be increased when Diclofenac is combined with Droxicam. The metabolism of Diclofenac can be decreased when combined with Manidipine. The risk or severity of adverse effects can be increased when Morniflumate is combined with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Medrysone. Diclofenac may increase the anticoagulant activities of Fondaparinux sodium. The risk or severity of adverse effects can be increased when Diclofenac is combined with ME-609. The serum concentration of Diclofenac can be decreased when it is combined with Siltuximab. The metabolism of Diclofenac can be decreased when combined with Indinavir. The risk or severity of adverse effects can be increased when Diclofenac is combined with Carprofen. Diclofenac may decrease the excretion rate of GPX-150 which could result in a higher serum level. The risk or severity of adverse effects can be increased when Diclofenac is combined with Balsalazide. Cholestyramine can cause a decrease in the absorption of Diclofenac resulting in a reduced serum concentration and potentially a decrease in efficacy. The metabolism of Diclofenac can be decreased when combined with Eslicarbazepine acetate. The metabolism of Diclofenac can be decreased when combined with Isradipine. The risk or severity of adverse effects can be increased when Lisinopril is combined with Diclofenac. Diclofenac may increase the anticoagulant activities of Dextran 70. The serum concentration of Diclofenac can be increased when it is combined with Capecitabine. The metabolism of Diclofenac can be decreased when combined with Esomeprazole. The risk or severity of adverse effects can be increased when Diclofenac is combined with Paramethasone. The risk or severity of adverse effects can be increased when Diclofenac is combined with Triamcinolone. The risk or severity of adverse effects can be increased when Diclofenac is combined with Ibuprofen. The metabolism of Diclofenac can be decreased when combined with Rabeprazole. The risk or severity of adverse effects can be increased when Diclofenac is combined with Prasterone sulfate. The metabolism of Diclofenac can be decreased when combined with Crizotinib. The serum concentration of Diclofenac can be increased when it is combined with Stiripentol. The risk or severity of adverse effects can be increased when Diclofenac is combined with Desoximetasone. The risk or severity of adverse effects can be increased when Diclofenac is combined with Floctafenine. The risk or severity of adverse effects can be increased when Diclofenac is combined with Adapalene. The risk or severity of adverse effects can be increased when Diclofenac is combined with Halcinonide. Diclofenac may increase the anticoagulant activities of Protein C. The serum concentration of Everolimus can be increased when it is combined with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Fluocinolone Acetonide. The risk or severity of adverse effects can be increased when Omapatrilat is combined with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Zileuton. The metabolism of Diclofenac can be decreased when combined with Fluvoxamine. The risk or severity of adverse effects can be increased when Diclofenac is combined with Clobetasol propionate. The serum concentration of Diclofenac can be decreased when it is combined with Secobarbital. The metabolism of Diclofenac can be decreased when combined with Pyrimethamine. Diclofenac may decrease the antihypertensive activities of Triamterene. Diclofenac may increase the anticoagulant activities of Letaxaban. Sodium phosphate may increase the nephrotoxic activities of Diclofenac. Diclofenac may decrease the antihypertensive activities of Indenolol. The risk or severity of adverse effects can be increased when Diclofenac is combined with Etoricoxib. Diclofenac may decrease the excretion rate of Gentamicin which could result in a higher serum level. Sarilumab may increase the immunosuppressive activities of Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Difluocortolone. The metabolism of Diclofenac can be decreased when combined with Cholecalciferol. Diclofenac may decrease the diuretic activities of Furosemide. The risk or severity of adverse effects can be increased when Diclofenac is combined with Bucillamine. The metabolism of Diclofenac can be decreased when combined with Ketoconazole. The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Diclofenac. The therapeutic efficacy of Dinoprost can be decreased when used in combination with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Azelastine. The metabolism of Diclofenac can be decreased when combined with Lopinavir. The metabolism of Diclofenac can be decreased when combined with Theophylline. The risk or severity of adverse effects can be increased when Diclofenac is combined with Nepafenac. The metabolism of Diclofenac can be decreased when combined with Zucapsaicin. Diclofenac may increase the anticoagulant activities of Edetic Acid. The risk or severity of adverse effects can be increased when Diclofenac is combined with Azapropazone. Diclofenac may decrease the excretion rate of Apramycin which could result in a higher serum level. Diclofenac may decrease the excretion rate of Streptozocin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Perindopril is combined with Diclofenac. The metabolism of Diclofenac can be decreased when combined with Valproic Acid. The serum concentration of Diclofenac can be increased when it is combined with Netupitant. The risk or severity of adverse effects can be increased when Diclofenac is combined with Flurbiprofen. The serum concentration of Silodosin can be increased when it is combined with Diclofenac. Diclofenac may decrease the antihypertensive activities of Befunolol. The risk or severity of adverse effects can be increased when Diclofenac is combined with PTC299. The risk or severity of adverse effects can be increased when Diclofenac is combined with Olsalazine. The risk or severity of adverse effects can be increased when Diclofenac is combined with Ketoprofen. The serum concentration of Vincristine can be increased when it is combined with Diclofenac. The metabolism of Diclofenac can be decreased when combined with Valsartan. The metabolism of Diclofenac can be decreased when combined with Fluoxetine. The metabolism of Diclofenac can be decreased when combined with Modafinil. The metabolism of Diclofenac can be decreased when combined with Crisaborole. The serum concentration of Diclofenac can be increased when it is combined with Aprepitant. The risk or severity of adverse effects can be increased when Diclofenac is combined with Parthenolide. The serum concentration of Bosutinib can be increased when it is combined with Diclofenac. The metabolism of Diclofenac can be decreased when combined with Clemastine. Diclofenac may decrease the excretion rate of Amikacin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Diclofenac is combined with Tranilast. The risk or severity of adverse effects can be increased when Diclofenac is combined with Chloroquine. The therapeutic efficacy of Folic Acid can be decreased when used in combination with Diclofenac. Diclofenac may decrease the excretion rate of Epirubicin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Diclofenac is combined with Mizoribine. Diclofenac may decrease the antihypertensive activities of Bopindolol. Diclofenac may decrease the antihypertensive activities of Bevantolol. Diclofenac may decrease the excretion rate of Amrubicin which could result in a higher serum level. The serum concentration of Diclofenac can be decreased when it is combined with Bosentan.